The effectiveness of nicotine-patch therapy for smoking cessation in patients with schizophrenia
- PMID: 14967189
- DOI: 10.1016/j.ijnurstu.2003.07.001
The effectiveness of nicotine-patch therapy for smoking cessation in patients with schizophrenia
Abstract
The purpose of this study was to determine the effectiveness of nicotine-patch therapy for smoking cessation in patients with schizophrenia. This was a longitudinal study and sixty-eight schizophrenic patients were assigned to 8 weeks of a nicotine-patch therapy program or a control group. The generalized estimating equation analysis revealed that there were significant reductions in the subjects' nicotine dependence (Fagerstrom Tolerance Questionnaire), the number of cigarettes per day, and CO levels over an 8-week period of nicotine-patch therapy and 3-month follow-up. The point-prevalence rates of abstinence from smoking were an abstinence of 26.9% at 8 weeks and 26.9% at a 3-month follow-up. At the 3-month follow-up, the rate of continuous smoking abstinence in the nicotine-patch group was 23.1%.
Similar articles
-
A 12-week double-blind, placebo-controlled study of bupropion sr added to high-dose dual nicotine replacement therapy for smoking cessation or reduction in schizophrenia.J Clin Psychopharmacol. 2007 Aug;27(4):380-6. doi: 10.1097/01.jcp.0b013e3180ca86fa. J Clin Psychopharmacol. 2007. PMID: 17632223 Clinical Trial.
-
Safety and efficacy of the nicotine patch and gum for the treatment of adolescent tobacco addiction.Pediatrics. 2005 Apr;115(4):e407-14. doi: 10.1542/peds.2004-1894. Pediatrics. 2005. PMID: 15805342 Clinical Trial.
-
Precessation treatment with nicotine patch significantly increases abstinence rates relative to conventional treatment.Nicotine Tob Res. 2009 Sep;11(9):1067-75. doi: 10.1093/ntr/ntp103. Epub 2009 Jun 30. Nicotine Tob Res. 2009. PMID: 19567826
-
Role of nicotine pharmacokinetics in nicotine addiction and nicotine replacement therapy: a review.Int J Tuberc Lung Dis. 2003 Sep;7(9):811-9. Int J Tuberc Lung Dis. 2003. PMID: 12971663 Review.
-
Clinical inquiries. What is the most effective nicotine replacement therapy?J Fam Pract. 2003 Jun;52(6):492-4. J Fam Pract. 2003. PMID: 12791233 Review. No abstract available.
Cited by
-
Pharmacotherapy of Co-Occurring Schizophrenia and Substance Use Disorders.Curr Addict Rep. 2014 Dec;1(4):251-260. doi: 10.1007/s40429-014-0034-7. Epub 2014 Sep 27. Curr Addict Rep. 2014. PMID: 27226947 Free PMC article.
-
A smoking ban in psychiatric units: threat or opportunity?Ment Health Fam Med. 2008 Sep;5(3):129-33. Ment Health Fam Med. 2008. PMID: 22477860 Free PMC article.
-
Effects of contingency management and bupropion on cigarette smoking in smokers with schizophrenia.Psychopharmacology (Berl). 2011 Sep;217(2):279-87. doi: 10.1007/s00213-011-2282-8. Epub 2011 Apr 8. Psychopharmacology (Berl). 2011. PMID: 21475970 Free PMC article. Clinical Trial.
-
Readiness to quit as a predictor for outcomes of smoking-reduction programme with transdermal nicotine patch or bupropion in a sample of 308 patients with schizophrenia.Eur Arch Psychiatry Clin Neurosci. 2015 Apr;265(3):249-57. doi: 10.1007/s00406-014-0515-7. Epub 2014 Jul 9. Eur Arch Psychiatry Clin Neurosci. 2015. PMID: 25005553
-
Interventions for smoking cessation and reduction in individuals with schizophrenia.Cochrane Database Syst Rev. 2013 Feb 28;2013(2):CD007253. doi: 10.1002/14651858.CD007253.pub3. Cochrane Database Syst Rev. 2013. PMID: 23450574 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical